Tonix Pharmaceuticals Holding Corp (TNXP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $58.49M
Last updated: Nov 17, 2026 at 11:06 AM ET
Tonix Pharmaceuticals Holding Corp (TNXP) Competitors
The companies most similar to Tonix Pharmaceuticals Holding are Tenax Therapeutics (TENX), Grace Therapeutics (GRCE) and Mink Therapeutics (INKT). By market cap, Tonix Pharmaceuticals Holding ranks 9th of the 13 companies on this page; Tenaya Therapeutics (TNYA) is the largest at $79.59M.
Peer Comparison
TNXP's revenue growth of 423.8% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding (TNXP) | $58.49M | N/A | 1.2x | 0.0% | N/A | 423.8% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Fortress Biotech Inc (FBIO) | $62.70M | 0.7x | 0.8x | 143.1% | 57.0% | 8.7% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Champions Oncology Inc (CSBR) | $65.49M | N/A | 1.0x | -1.9% | N/A | 8.8% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Nutriband Inc (NTRB) | $74.15M | N/A | 43.7x | 0.0% | -101.3% | -29.7% | 0.00% |
| Neuraxis, Inc. (NRXS) | $76.93M | N/A | 9.6x | -144.4% | -247.7% | 115.7% | 0.00% |
| Peer median | $65.07M | 2.4x | 5.5x | 0.0% | -135.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Tonix Pharmaceuticals Holding, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Fortress Biotech Inc (FBIO) | Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. | FBIO competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
| Champions Oncology Inc (CSBR) | Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. | CSBR competitors |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Nutriband Inc (NTRB) | Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida. | NTRB competitors |
| Neuraxis, Inc. (NRXS) | NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana. | NRXS competitors |
Frequently Asked Questions About TNXP
Who are Tonix Pharmaceuticals Holding's main competitors?
The companies most similar to Tonix Pharmaceuticals Holding include Tenax Therapeutics (TENX), Grace Therapeutics (GRCE), Mink Therapeutics (INKT), Tiziana Life Sciences (TLSA) and Fortress Biotech (FBIO), listed from the closest match.
Who is Tonix Pharmaceuticals Holding's biggest competitor?
Tenaya Therapeutics (TNYA) is the largest of the similar companies at $79.59M; Tenax Therapeutics (TENX) is the closest match by business profile, size, sector and industry.
How does TNXP stock compare with its competitors?
TNXP's P/S is 1.2x against a peer median of 5.5x; its net margin is 0.0% against a peer median of 0.0%.
Which of Tonix Pharmaceuticals Holding's competitors pays a higher dividend?
Tonix Pharmaceuticals Holding pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Tonix Pharmaceuticals Holding bigger than its competitors?
No. Tonix Pharmaceuticals Holding is 9th by market cap among the 13 companies on this page; the largest is Tenaya Therapeutics (TNYA) at $79.59M.
TNXP pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors